Bionomics Limited(BNOX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

BNOX Bionomics Limited

Halted 12-23 16:00:00 EST

0.2531

+0.0000

0.00%

High0.2531	Low0.2531	Vol0.00
Open0.2531	D1 Closing0.2531	Amplitude0.00%
Mkt Cap4.94M	Tradable Cap4.23M	Total Shares19.53M
T/O2.68M	T/O Rate0.00%	Tradable Shares16.73M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"BNOX","market":"US","secType":"STK","nameCN":"Bionomics Limited","latestPrice":0.2531,"timestamp":1734987600000,"preClose":0.2531,"halted":3,"volume":0,"delay":0,"floatShares":16731500,"shares":19527349,"eps":-0.916611,"marketStatus":"Halted","change":0,"latestTime":"12-23 16:00:00 EST","open":0.2531,"high":0.2531,"low":0.2531,"amount":2682836.16072948,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.916611,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1765184400000},"marketStatusCode":7,"adr":0,"adrRate":180,"listingDate":1639630800000,"exchange":"NASDAQ","adjPreClose":0.2531,"volumeRatio":0},"requestUrl":"/m/hq/s/BNOX","defaultTab":"news","newsList":[{"id":"2492677640","title":"Bionomics Announces Supreme Court of New South Wales Approves Bionomics’ Re-Domiciliation","url":"https://stock-news.laohu8.com/highlight/detail?id=2492677640","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492677640?lang=en_us&edition=fundamental","pubTime":"2024-12-17 05:05","pubTimestamp":1734383100,"startTime":"0","endTime":"0","summary":"ADELAIDE, Australia,and CAMBRIDGE, Mass., Dec.  16, 2024  (GLOBE NEWSWIRE) -- Bionomics Limited (Nasdaq: BNOX) (Bionomics or Company) is pleased to announce that the Supreme Court of New South Wales, ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/12/16/2997880/0/en/Bionomics-Announces-Supreme-Court-of-New-South-Wales-Approves-Bionomics-Re-Domiciliation.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BNOX","BK4139"],"gpt_icon":0},{"id":"2491354101","title":"Results of Scheme Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2491354101","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491354101?lang=en_us&edition=fundamental","pubTime":"2024-12-13 05:05","pubTimestamp":1734037500,"startTime":"0","endTime":"0","summary":"ADELAIDE, Australia and CAMBRIDGE, Mass., Dec.  12, 2024  (GLOBE NEWSWIRE) -- Bionomics Limited (Nasdaq: BNOX) (“Bionomics” or the “Company”) is pleased to provide the following update on the status o","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/12/12/2996518/0/en/Results-of-Scheme-Meeting.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BNOX","BK4139"],"gpt_icon":0},{"id":"2490724991","title":"Bionomics Publishes the Positive Results from the Phase 2 ATTUNE Study of BNC210 in Patients with Post-Traumatic Stress Disorder in NEJM Evidence","url":"https://stock-news.laohu8.com/highlight/detail?id=2490724991","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490724991?lang=en_us&edition=fundamental","pubTime":"2024-12-09 21:00","pubTimestamp":1733749200,"startTime":"0","endTime":"0","summary":"BNC210 improved PTSD symptom severity at Week 12 with efficacy observed as early as Week 4Company plans to initiate a Phase 3 study of BNC210 in PTSD in H2 2025 ADELAIDE, Australia,and CAMBRIDGE, Mass","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/12/09/2993718/0/en/Bionomics-Publishes-the-Positive-Results-from-the-Phase-2-ATTUNE-Study-of-BNC210-in-Patients-with-Post-Traumatic-Stress-Disorder-in-NEJM-Evidence.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["POST","BK4135","BK4212","BK4139","CNS","BNOX"],"gpt_icon":0},{"id":"2488981613","title":"Bionomics Reminds Shareholders to Cast their Vote for Re-Domiciliation from Australia to the United States","url":"https://stock-news.laohu8.com/highlight/detail?id=2488981613","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488981613?lang=en_us&edition=fundamental","pubTime":"2024-12-03 06:01","pubTimestamp":1733176860,"startTime":"0","endTime":"0","summary":"ADELAIDE, Australia,and CAMBRIDGE, Mass., Dec.  02, 2024  (GLOBE NEWSWIRE) -- Bionomics Limited (Nasdaq: BNOX) (Bionomics or Company), a clinical-stage biotechnology company developing novel, first-in","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/12/02/2990184/0/en/Bionomics-Reminds-Shareholders-to-Cast-their-Vote-for-Re-Domiciliation-from-Australia-to-the-United-States.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4135","UBCP","CNS","BNOX","BK4139","BK4211"],"gpt_icon":0},{"id":"2482566864","title":"Bionomics Provides an Update on Re-domiciliation via Scheme of Arrangement","url":"https://stock-news.laohu8.com/highlight/detail?id=2482566864","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482566864?lang=en_us&edition=fundamental","pubTime":"2024-11-09 05:15","pubTimestamp":1731100500,"startTime":"0","endTime":"0","summary":"ADELAIDE, Australiaand CAMBRIDGE, Mass., Nov.  08, 2024  (GLOBE NEWSWIRE) -- Bionomics Limited (Nasdaq: BNOX) (Bionomics or Company), a clinical-stage biotechnology company developing novel, first-in-","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"38e1dcfcc6c1676d83876d6a32ce591e","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/11/08/2977881/0/en/Bionomics-Provides-an-Update-on-Re-domiciliation-via-Scheme-of-Arrangement.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CNS","BK4135","BK4139","BNOX"],"gpt_icon":1},{"id":"2481157782","title":"ADRs Advance; Bionomics Ltd. Climbs 36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481157782","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481157782?lang=en_us&edition=fundamental","pubTime":"2024-11-08 05:31","pubTimestamp":1731015060,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.International stocks trading in New York closed higher on Thursday, as the S&P/BNY Mellon index of American depositary receipts gained 1.8% to 186.24.The European index gained 1.3% to 170.22. The Asian index rose 2.6% to 239.71. The Latin American index added 0.7% to 191.77, while the emerging-markets index rose 2.8% to 396.82.Australia's Bionomics Ltd. was the biggest leader during the session, soaring 36% to 38 cents, and China-based Agora Inc. rocketed 22% to $3.78. CNFinance Holdings Ltd., which is based in China, rounded out the top three leaders on Thursday, with shares rocketing 20% to $1.32.Oatly Group AB, based in Sweden, posted the largest decline, tumbling 17% to 77 cents, followed by shares of Germany's Jumia Technologies AG, which tumbled 17% to $4.00. Shares of Japan-based Pixie Dust Technologies Inc. plunged 14% to 69 cents.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2308191902.HKD","BNOX","BK4548","BK4539","BK4212","OTLY"],"gpt_icon":1},{"id":"2481902921","title":"Bionomics to Present at the 2024 CNS Summit","url":"https://stock-news.laohu8.com/highlight/detail?id=2481902921","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481902921?lang=en_us&edition=fundamental","pubTime":"2024-11-07 21:00","pubTimestamp":1730984400,"startTime":"0","endTime":"0","summary":"ADELAIDE, Australia and CAMBRIDGE, Mass., Nov.  07, 2024  (GLOBE NEWSWIRE) -- Bionomics Limited (Nasdaq: BNOX) (Bionomics or Company), a clinical-stage biotechnology company developing novel, first-in","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/11/07/2976623/0/en/Bionomics-to-Present-at-the-2024-CNS-Summit.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CNS","BNOX","SMMF","BK4211","BK4135"],"gpt_icon":0},{"id":"2481632020","title":"Bionomics Shares Surge After Carina Biotech Milestone Payment","url":"https://stock-news.laohu8.com/highlight/detail?id=2481632020","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481632020?lang=en_us&edition=fundamental","pubTime":"2024-11-06 03:24","pubTimestamp":1730834662,"startTime":"0","endTime":"0","summary":"Bionomics  shares surged over 165% in recent trading on Tuesday after the company said it received a milestone payment of AU$1 million  from Carina Biotech for BNC101, one of its partnered legacy oncology programs.The payment was made on Oct. 30 under the exclusive, worldwide license agreement for cancer treatment candidate BNC101, Bionomics added.The company said it is eligible to receive up to AU$118 million from Carina Biotech conditional on the achievement of certain development, regulatory and commercial milestones.Price: 0.51, Change: +0.32, Percent Change: +165.10","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","BNOX"],"gpt_icon":0},{"id":"2481632394","title":"Top Midday Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2481632394","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481632394?lang=en_us&edition=fundamental","pubTime":"2024-11-06 03:08","pubTimestamp":1730833711,"startTime":"0","endTime":"0","summary":"Bionomics (BNOX) said late Monday it received a milestone payment of 1 million Australian dollars ($663,200) from Carina Biotech for BNC101, a partnered legacy oncology program.Bionomics stock more th","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","BK4585","BK4588","BK4230","BNOX","BK4023","LU1861558580.USD","LU1861559042.SGD","ZCAR","PLTR","BK4547","BK4543"],"gpt_icon":1},{"id":"2481631688","title":"S&P 500 Gains 1%; Vimeo Shares Spike Higher","url":"https://stock-news.laohu8.com/highlight/detail?id=2481631688","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481631688?lang=en_us&edition=fundamental","pubTime":"2024-11-06 02:36","pubTimestamp":1730831776,"startTime":"0","endTime":"0","summary":" ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/24/11/41754396/s-p-500-gains-1-vimeo-shares-spike-higher","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":[".SPX","VRCA","OEX","BK4561","BNOX","BVS","OEF","ZVSA","BK4551","BK4007","SPY","VOO","QLD",".IXIC","BK4534","BK4227","SDS","SPXU","SQQQ","TQQQ","BK4585","BK4539","BK4581","BK4535","MNQmain","NQmain","BK4588","BK4504","BK4550","BK4139","UPRO","SSO","VMEO","QID","MQ","ESmain","BK4106","BK4198","PSQ","IVV","SH","BK4559","BK4077"],"gpt_icon":1},{"id":"2481552729","title":"Bionomics Receives Milestone Payment of AUS$1M from Carina Biotech for BNC101 Partnered Legacy Oncology Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2481552729","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481552729?lang=en_us&edition=fundamental","pubTime":"2024-11-05 05:15","pubTimestamp":1730754900,"startTime":"0","endTime":"0","summary":"ADELAIDE, Australia and CAMBRIDGE, Mass., Nov.  04, 2024  (GLOBE NEWSWIRE) -- Bionomics Limited (Nasdaq: BNOX) (Bionomics or Company), a clinical-stage biotechnology company developing novel, first-in","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/11/04/2974465/0/en/Bionomics-Receives-Milestone-Payment-of-AUS-1M-from-Carina-Biotech-for-BNC101-Partnered-Legacy-Oncology-Program.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BNOX","BK4561","CNS","AUS","BK4135"],"gpt_icon":1},{"id":"2475363165","title":"Bionomics to Participate in the 2024 Maxim Healthcare Virtual Summit, Presented by Maxim Group LLC","url":"https://stock-news.laohu8.com/highlight/detail?id=2475363165","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2475363165?lang=en_us&edition=fundamental","pubTime":"2024-10-14 20:00","pubTimestamp":1728907200,"startTime":"0","endTime":"0","summary":"ADELAIDE, Australiaand CAMBRIDGE, Mass., Oct.  14, 2024  (GLOBE NEWSWIRE) -- Bionomics Limited (Nasdaq: BNOX) (Bionomics or Company), a clinical-stage biotechnology company developing novel, first-in-","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/10/14/2962494/0/en/Bionomics-to-Participate-in-the-2024-Maxim-Healthcare-Virtual-Summit-Presented-by-Maxim-Group-LLC.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CNS","MNQmain","NQmain","PSQ","BK4137","HCSG","SQQQ","TQQQ","BK4135","QID","BK4139","QLD","SMMF","BK4211",".IXIC","BNOX"],"gpt_icon":1},{"id":"2473174678","title":"Bionomics Issues Shareholder Letter Highlighting Recent Achievements and Strategic Vision","url":"https://stock-news.laohu8.com/highlight/detail?id=2473174678","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2473174678?lang=en_us&edition=fundamental","pubTime":"2024-10-07 20:00","pubTimestamp":1728302400,"startTime":"0","endTime":"0","summary":"ADELAIDE, Australia,and CAMBRIDGE, Mass., Oct.  07, 2024  (GLOBE NEWSWIRE) -- Bionomics Limited (Nasdaq: BNOX) (Bionomics or Company), a clinical-stage biotechnology company developing novel, first-in","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/10/07/2958885/0/en/Bionomics-Issues-Shareholder-Letter-Highlighting-Recent-Achievements-and-Strategic-Vision.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CNS","BK4135","BNOX","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.bionomics.com.au","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":-0.1122},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":0.0034},{"period":"1month","weight":0.012},{"period":"3month","weight":0.0594},{"period":"6month","weight":0.1445},{"period":"1year","weight":0.1303},{"period":"ytd","weight":0.17}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Bionomics Limited, a clinical stage biopharmaceutical company, discovers and develops novel drug candidates for the treatment of central nervous system disorders and cancers. The company's lead drug candidate includes BNC210, a negative allosteric modulator of the a7 nicotinic acetylcholine receptor, which is in phase 2 clinical trial for the treatment of social anxiety disorder and phase 2b to treat post-traumatic stress disorder. It also develops BNC101, a monoclonal antibody that has completed phase 1 clinical trial that targets cancer stem cells; and BNC105, which is in phase 2 clinical trial for the treatment of refractory colorectal cancer and phase 1 clinical trial for the treatment of patients with relapsed/refractory chronic lymphocytic leukemia. The company has a collaboration with Merck & Co., Inc. to identify novel a7 Nicotinic Acetylcholine Receptor PAMs suitable for the treatment of cognitive disorder. Bionomics Limited was incorporated in 1996 and is based in Eastwood, Australia.","yearOnYearQuotes":[{"month":1,"riseRate":0,"avgChangeRate":-0.197233},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.019763},{"month":3,"riseRate":0,"avgChangeRate":-0.156448},{"month":4,"riseRate":0,"avgChangeRate":-0.098216},{"month":5,"riseRate":0,"avgChangeRate":-0.053297},{"month":6,"riseRate":0,"avgChangeRate":-0.057104},{"month":7,"riseRate":0,"avgChangeRate":-0.112132},{"month":8,"riseRate":0.666667,"avgChangeRate":0.042318},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.000842},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.106408},{"month":11,"riseRate":0.333333,"avgChangeRate":-0.03563},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.123705}],"exchange":"NASDAQ","name":"Bionomics Limited","nameEN":"Bionomics Limited"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.9","shortVersion":"4.35.9","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Bionomics Limited(BNOX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Bionomics Limited(BNOX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Bionomics Limited,BNOX,Bionomics Limited股票,Bionomics Limited股票老虎,Bionomics Limited股票老虎国际,Bionomics Limited行情,Bionomics Limited股票行情,Bionomics Limited股价,Bionomics Limited股市,Bionomics Limited股票价格,Bionomics Limited股票交易,Bionomics Limited股票购买,Bionomics Limited股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Bionomics Limited(BNOX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Bionomics Limited(BNOX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction